Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SmartKem Further Expands Team in Europe with Addition of Three New Recruits

Published: Monday, February 11, 2013
Last Updated: Monday, February 11, 2013
Bookmark and Share
COO and two scientists to join the Manchester team to support SmartKem’s growth plans.

SmartKem Limited has announced the appointment of three new team members in Europe. Dr. Hugh Williamson will be welcomed as Chief Operating Officer, whilst Dr. Muhammad Raza and Dr. Keith Lumbard will join as scientists at SmartKem’s dedicated chemistry synthesis labs in Manchester.

The last 12 months has seen SmartKem appoint staff in strategic locations across Asia and Europe to further strengthen its technical and commercial activities.

As SmartKem’s third senior appointment in the past six months, following the appointment of Bill Freer as Chairman in March and Gary Tam as Business Development Director in June, Dr. Williamson possesses over 30 years’ experience in the chemicals industry which will be shared in his position as Chief Operating Officer.

Previous roles have seen Dr. Williamson excel in the delivery and introduction of new chemical products at international level.

Having spent a number of years as a senior scientist at Kodak, Dr. Williamson’s global experience and proven ability to lead R&D and operations teams will be essential in supporting SmartKem’s commercialization strategy and the development of future technology.

Possessing over 40 years’ combined experience as synthetic chemists, Dr. Lumbard and Dr. Raza will be responsible for the development of next generation organic semiconductor molecules with enhanced performance to complement SmartKem’s already market-leading materials.

“Our latest recruits are another step forward in our vision to become the leading provider of high-mobility organic semiconductor materials and solutions for flexible display backplanes and organic circuits,’’ comments Steve Kelly, CEO at SmartKem.

Kelly continued, “Hugh was a natural appointment for us as Chief Operating Officer with his strong record of scaling novel organic synthesis methods into commercial processes. This further supports our strategy to maintain strong vertical integration in organic electronics - from molecule design to market application. The appointments of Keith and Muhammad as additional synthetic chemists demonstrate our commitment to develop ultra-high mobility organic semiconductors to meet future-market needs and to extend our leadership in the field. We are delighted to welcome them to the team.”

These new appointments promise to add strength, experience and expertise to the company in order to further develop its presence in the rapidly growing flexible electronics industry.

Together, the new members of the team will further support SmartKem’s mission of becoming the leading provider of, ‘p’ type organic semiconductor materials and solutions for ultra-thin and flexible electronics.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Drug Leads Identified to Combat Heart Disease
Using three supercomputers, researchers surveyed protein structures through accelerated molecular dynamics.
Accelerating the Path to Molecules for Medicine
Researchers convert carbon-hydrogen bonds into nitriles - converting organic molecules into components of medicines.
Game Changing Antibacterial Drug Research
Researchers publish report on the synthesis of a newly discovered “game-changing” antibiotic, Teixobactin.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
New Way of Displaying 3D Molecular Structures
Metal-organic frameworks provide a new platform for solving the structure of hard-to-study samples.
Agent Blocks Pain Without Morphine's Side Effects
Scientists have synthesised a molecule with specific pain-relief properties and has shown its efficacy in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!